SG Eyes Pharma, Biotech Offering As M&A Spikes
May 13, 2015
Société Générale is to launch open-end certificates on a pharma and biotech opportunity index to retail and private banking clients in Germany and Austria following increased M&A activity in the healthcare industry.
Restricted content
You must be an EQD+ subscriber to view this page. Either sign in or see below on how to request a trial.
Get access now
Request access today
Questions? Need access for multiple users?
Contact eqdplus@eqderivatives.com